Clinical trial
Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed…
NCT00129194 · Koronis Pharmaceuticals., Industry · Completed
Key facts
| NCT number | NCT00129194 |
|---|---|
| Title | Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens |
| Official title | A Double-Blind, Placebo-Controlled, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of KP-1461 in HIV+ Adults Who Have Failed Two or More Highly Active Antiretroviral Regimens (HAART) |
| Lead sponsor | Koronis Pharmaceuticals., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | KP-1461 |
| Enrollment | 40 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2007 |
| First posted | Aug 11, 2005 |
| Last update posted | Jan 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: